{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:29:17Z","timestamp":1791178157803,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jhep.2014.07.034","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T04:23:02Z","timestamp":1407903782000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study"],"prefix":"10.1016","volume":"62","author":[{"given":"Lluis","family":"Castells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Rimola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Manzardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Barcena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Abradelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Xiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Antela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Laguno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ag\u00fcero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Esteban-Mur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Miro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.07.034_b0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.07.034_b0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1468-1293.2007.00468.x","article-title":"Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area","volume":"8","author":"Martinez","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.jhep.2014.07.034_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0032-1316474","article-title":"Liver transplantation in HIV patients","volume":"32","author":"Fox","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.07.034_b0020","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.jhep.2005.11.028","article-title":"Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?","volume":"44","author":"Miro","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.034_b0025","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1600-6143.2006.01546.x","article-title":"Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C","volume":"6","author":"de Vera","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2014.07.034_b0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"47","author":"Duclos-Vallee","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.034_b0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0040","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1600-6143.2012.04028.x","article-title":"Outcome of HCV\/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study","volume":"12","author":"Miro","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2014.07.034_b0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.tp.0000251378.70853.90","article-title":"Liver transplantation in HIV-HCV coinfected patients: a case-control study","volume":"83","author":"Castells","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2014.07.034_b0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/QAD.0b013e328344febb","article-title":"Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort","volume":"25","author":"Cooper","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.034_b0055","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1002\/lt.20261","article-title":"Liver transplantation in patients with HIV infection","volume":"10","author":"Fung","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0060","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.transproceed.2007.05.076","article-title":"Liver transplantation in HIV-positive patients","volume":"39","author":"Vennarecci","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2014.07.034_b0065","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e3280d5a79a","article-title":"Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort","volume":"21","author":"Wojcik","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.034_b0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.12668","article-title":"Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients","volume":"14","author":"Terrault","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2014.07.034_b0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0025-7753(02)73506-9","article-title":"Liver transplantation in a patient infected by human immunodeficiency virus","volume":"119","author":"Rafecas","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jhep.2014.07.034_b0080","first-page":"353","article-title":"GESIDA\/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)","volume":"23","author":"Miro","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.jhep.2014.07.034_b0085","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/lt.21890","article-title":"Evolution of hepatitis C virus in liver allografts","volume":"15","author":"Demetris","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.07.034_b0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons","volume":"351","author":"Chung","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.07.034_b0100","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","article-title":"Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial","volume":"292","author":"Carrat","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.07.034_b0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.07.034_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.07.034_b0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.aids.0000206500.16783.2e","article-title":"Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV\/hepatitis C virus co-infection","volume":"20","author":"Graham","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.034_b0120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/lt.20737","article-title":"Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C","volume":"12","author":"Berenguer","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0125","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1600-6143.2011.03608.x","article-title":"Fibrosing cholestatic hepatitis in HIV\/HCV co-infected transplant patients-usefulness of early markers after liver transplantation","volume":"11","author":"Antonini","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2014.07.034_b0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/MCG.0b013e31825833be","article-title":"Peginterferon-alpha-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation","volume":"46","author":"Gordon","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2014.07.034_b0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.034_b0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lt.23516","article-title":"Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis","volume":"19","author":"Rabie","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.034_b0150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1600-6143.2007.02126.x","article-title":"Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation","volume":"8","author":"Berenguer","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2014.07.034_b0155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1432-2277.2012.01571.x","article-title":"Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients","volume":"26","author":"Tanaka","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2014.07.034_b0160","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/lt.23542","article-title":"Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data","volume":"18","author":"Werner","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation, a multicenter experience","volume":"60","author":"Coilly","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.034_b0170","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/lt.23669","article-title":"Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation","volume":"19","author":"Pungpapong","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.07.034_b0175","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/01.aids.0000432539.77711.f4","article-title":"Successful anti-hepatitis C virus therapy with telaprevir in an HIV\/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft","volume":"27","author":"Antonini","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.07.034_b0180","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.1016\/S0168-8278(14)61392-1","article-title":"Sofosbuvir and ribavirin for the treatment of recurrent hepatitis C infection after liver transplantation: results of a prospective, multicenter study","volume":"60","author":"Samuel","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.07.034_b0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2014.7734","article-title":"Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection","volume":"312","author":"Sulkowski","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.07.034_b0190","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2015.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814005388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814005388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:52:28Z","timestamp":1538355148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814005388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0168827814005388"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.07.034","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jhep.2015.12.001","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}